Table 1.
Baseline characteristics of EC patients before enteral nutrition
| Variable | NGT group (n = 46) |
ONS group (n = 68) |
t/χ2 | P value |
|---|---|---|---|---|
| Age (year), mean ± SD | 67.30 ± 7.12 | 67.00 ± 8.52 | 0.19 | 0.85 |
| Gender (%, n) | ||||
| Male | 80.43 (37/46) | 64.71 (44/68) | 3.30 | 0.07 |
| Female | 19.57 (9/46) | 35.29 (24/68) | ||
| Height (cm), mean ± SD | 166.46 ± 6.32 | 165.22 ± 8.04 | 0.92 | 0.36 |
| Weight (kg), mean ± SD | 57.36 ± 8.67 | 59.34 ± 9.57 | − 1.12 | 0.26 |
| BMI (kg/m2), mean ± SD | 20.67 ± 2.64 | 21.72 ± 3.12 | − 1.87 | 0.06 |
| NRS2002 score, mean ± SD | 3.57 ± 0.62 | 3.66 ± 0.56 | − 0.86 | 0.39 |
| PG-SGA score, mean ± SD | 11.41 ± 2.10 | 10.85 ± 2.38 | 1.29 | 0.20 |
| Grade B | 6 | 16 | 1.94 | 0.16 |
| Grade C | 40 | 52 | ||
|
Total energy intake (kcal·kg−1·d−1), mean ± SD |
1180.57 ± 273.93 | 1260.95 ± 287.50 | − 1.49 | 0.14 |
| Tumor site (%, n) | ||||
| Neck | 13.04 (6/46) | 10.29 (7/68) | 0.21 | 0.65 |
| Thoracic segment | 86.96 (40/46) | 89.71 (61/68) | ||
| Tumor staging (%, n) | ||||
| I–II | 13.04 (6/46) | 22.06 (15/68) | 1.48 | 0.22 |
| III–IV | 86.96 (40/46) | 77.94 (53/68) | ||
| Treatment (%, n) | ||||
| Radical chemoradiotherapy | 58.70 (27/46) | 45.59 (31/68) | − 1.28 | 0.20 |
| Adjuvant chemoradiotherapy | 39.13 (18/46) | 52.94 (36/68) | ||
| Palliative chemoradiotherapy | 2.17 (1/46) | 1.47 (1/68) | ||
EC, esophageal cancer; BMI, body mass index; NRS2002, Nutritional Risk Screening 2002; PG-SGA, Patient-Generated Subjective Global Assessment; SD, standard deviation; NGT, nasogastric tube; ONS, oral nutritional supplementation